Introduction {#s1}
============

*Salmonella enterica* serovar Typhimurium is a rod-shaped enteric bacterium which easily infects diverse hosts such as humans, cattle, poultry and reptiles through contaminated food or water, causing gastroenteritis. A human-restricted serovar of *Salmonella enterica*, serovar Typhi, causes typhoid fever and continues to be a dangerous pathogen throughout the world. *Salmonella* lives as a facultative pathogen in various natural and artificial environments as independent planktonic cells, cooperative swarms ([@bib22]) or as multi-cellular communities called biofilms (see [@bib40] for a review). Upon successful invasion of host cells, *Salmonella* is phagocytosed by macrophages, where it resides in a modified vacuole in a self-nourishing niche called a Salmonella-Containing Vacuole (SCV). This intracellular lifestyle eventually adversely affects the host. *Salmonella* also resides as multi-cellular communities on intestinal epithelial cells ([@bib4]), gallstones ([@bib36]) and tumors ([@bib12]). It is believed that biofilms in the gall bladder are important for maintaining the carrier state, allowing *Salmonella* to persist ([@bib11]).

Each of these lifestyles of *Salmonella* are regulated by two-component regulatory systems (TCRS). TCRSs are comprised of a membrane-bound sensor histidine kinase and a cytoplasmic response regulator. The virulence genes of *Salmonella* are encoded on horizontally acquired AT-rich segments of the genome called Salmonella Pathogenecity Islands (SPIs), and are also tightly regulated by TCRSs. For example, the SsrA/B TCRS is essential for the activation of the SPI-2 regulon genes encoding a type-three secretory needle and effectors that are involved in formation of the SCV ([@bib8]). Interestingly, the SsrA/B system itself is regulated by upstream two-component systems such as EnvZ/OmpR and PhoP/Q, which regulate gene expression in response to changes in osmolality, pH and the presence of anti-microbial peptides ([@bib17]; [@bib32]; [@bib26]; [@bib15]). The *ssrA* and *ssrB* genes are present on the SPI-2 pathogenecity island adjacent to each other and are regulated by a set of divergent promoters ([@bib15]; [@bib34]). Under acidic pH and low osmolality, the *ssrA* and *ssrB* genes are transcriptionally activated by the binding of OmpR\~P and PhoP\~P to their promoters ([@bib15]; [@bib3]; Walthers and Kenney unpublished) whose levels are in turn regulated by the respective sensor kinases, EnvZ and PhoQ. SsrA is a tripartite membrane-bound histidine sensor kinase that undergoes a series of intra-molecular phosphorylation reactions before it transfers the phosphoryl group to the N-terminal aspartate residue of the response regulator, SsrB.

SsrB belongs to the NarL/FixJ family of transcriptional regulators that require phosphorylation-dependent dimerization to bind DNA. The X-ray crystal structure of NarL revealed that the C-terminal DNA binding domain was occluded by the N-terminus ([@bib2]), and phosphorylation was predicted to relieve this inhibition. Full-length SsrB is unstable in solution, but an isolated C-terminal domain of SsrB, SsrBc, is capable of binding to the regulatory regions of nine genes belonging to the SPI-2 regulon, including *ssrA* and *ssrB* ([@bib16]; [@bib42]) and activating transcription. A role for SsrB\~P was identified by its dual function as a direct transcriptional activator and as an anti-silencer of H-NS-mediated repression ([@bib42]). The Histone like Nucleoid Structuring protein H-NS is involved in silencing many of the SPI-2 regulon genes in accordance with its role in binding to xenogenic AT-rich sequences and repressing their expression ([@bib42]; [@bib33]). H-NS binding to DNA leads to the formation of a stiff nucleoprotein filament which is essential in gene silencing ([@bib27]; [@bib28]; [@bib1]; [@bib48]). Moreover, relief of repression occurs due to the binding of SsrBc to this rigid H-NS-DNA complex ([@bib43]).

*Salmonella* reservoirs in host and non-host environments produce a three-dimensional extracellular matrix which consists of curli fimbriae, cellulose, proteins and extracellular DNA, to encase clusters of bacteria and form a mature biofilm. CsgD (AgfD) is the master regulator of biofilm formation ([@bib18]); it is a LuxR family transcriptional activator that activates the expression of curli fimbriae encoded by *csgDEFG/csgBAC* operons ([@bib9]; [@bib37]). CsgD also activates expression of *adrA*, increasing intracellular c-di-GMP levels, and activating the cellulose biosynthetic operon *bcsABZC* ([@bib50]). Two other biofilm matrix components are also positively regulated by CsgD: BapA and the O-antigen capsule ([@bib25]; [@bib19]).

Transcriptional profiling of biofilms formed by *S*. Typhimurium SL1344 showed that many SPI-2 genes were down-regulated, yet SsrA was required for biofilms ([@bib21]). This apparent paradox drove us to explore the underlying mechanism of biofilm formation. The role of SsrA/B in this process was of particular interest, since our previous comparison of SsrA and SsrB levels at neutral and acidic pH had shown that the expression of *ssrA* and *ssrB* was uncoupled ([@bib16]).

We examined the ability of the wild type *S*. Typhimurium strain 14028s to form biofilms in the absence of *ssrA* and *ssrB* and found it to be dependent only on the expression of *ssrB*. We further showed that H-NS was a negative regulator of *csgD.* Surprisingly, the SsrB response regulator positively regulated the formation of biofilms by activating *csgD* expression in the absence of any phospho-donors. Moreover, AFM imaging revealed that unphosphorylated SsrB was able to bind to the *csgD* regulatory region and binding was sufficient to relieve H-NS-mediated repression and favor formation of *S*. Typhimurium biofilms.

As a result of these studies, we propose that SsrB, a pathogenicity island-2-encoded response regulator, sits at a pivotal position in governing *Salmonella* lifestyle fate: to either exist inside the host (in the SCV) as a promoter of virulence; or as a surface-attached multicellular biofilm, maintaining the carrier state. This switch is achieved merely by the ability of unphosphorylated SsrB to function as an anti-repressor of H-NS and the additional role of SsrB\~P in activating SPI-2 transcription ([@bib43]).

Results {#s2}
=======

SsrB supports biofilm formation in the absence of its kinase SsrA {#s2-1}
-----------------------------------------------------------------

The SsrA/B TCRS is activated by environmental stimuli such as pH and osmolality, stimulating the expression of virulence genes essential for intra-cellular growth and survival of *Salmonella* ([@bib15]; [@bib16]). Thus, it was surprising that SsrA/B and SPI-2 were implicated in the multi-cellular lifestyle of *Salmonella* ([@bib21]). Furthermore, the SsrA kinase was required, but SPI-2 genes were down-regulated. At SPI-2, SsrB\~P de-represses H-NS and also activates transcription ([@bib42]; [@bib43]). We therefore wanted to explore this seeming paradox during biofilm regulation.

In order to quantify the defect in biofilm-forming ability resulting from the absence of *ssrB*, the wild type strain 14028s, an *ssrA* null strain and an *ssrB* null strain were grown in 96-well polystyrene microtiter plates for 2 days. The surface-attached cells in 14028s, *ssrA* and *ssrB* strains were stained by crystal-violet and quantified. As shown in the figure, biofilm levels in the *ssrB* mutant strain decreased by around 60% compared to the wild type or an *ssrA* null strain ([Figure 1A](#fig1){ref-type="fig"}), and it could be complemented by over-expressing SsrBc *in trans.* Thus, we establish a new role for SsrB, but not the SsrA kinase in positively regulating biofilm formation. The *ssrB* strain was not compromised for planktonic growth, as measured by total viable counts of the wild type, *ssrA* and *ssrB* cultures ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and Supplementary methods).10.7554/eLife.10747.003Figure 1.Loss of *ssrB* but not *ssrA* decreases *Salmonella* Typhimuirum biofilms.(**A**) The defect in formation of biofilms in the *ssrB* null was complemented by the overexpression of SsrBc from plasmid pKF104 *in trans* as measured by crystal violet staining. (**B**) The typical rdar morphotype of the wild type strain was lost in the *ssrB* strain as shown on congo red plates. (**C**) A two day old macrocolony of the *ssrB* strain is not fluorescent under UV light with Fluorescent Brightener 28. (**D**) The wild type strain forms thick solid-surface biofilms, while the *ssrB* strain remains poor for biofilms as monitored for six days by SYTO-9 staining of flow cell biofilms; scale bar = 1 mm. (**E**) SEM images showing extensive mesh-like network of wild type biofilms and sparse extracellular matrix of the *ssrB* biofilms; scale bar = 1 µm. (**F**) The amount of biofilms formed by the wild type strain (solid black bars) increases after 24 hr but the *ssrB* null (hatched black bars) remains defective up to 84 hr. n = 2, Mean ± SD, p \< 0.0001 between wild type and *ssrB* strains from 36 hr till 84 hr. (**G**) The amount of cholesterol-attached biofilms formed by the *ssrB* strain were significantly less than that produced by the wild type. n = 3, Mean ± SD, p \< 0.0001. Source data file: [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.003](10.7554/eLife.10747.003)10.7554/eLife.10747.004Figure 1---source data 1.Source data for crystal violet staining in [Figure 1A,F and G](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.004](10.7554/eLife.10747.004)10.7554/eLife.10747.005Figure 1---figure supplement 1.The *ssrB* mutant is not defective in growth compared to the wild type strain.Number of colonies formed by the wild type, *ssrA, ssrB* and D56A strains were the same order of magnitude across all the time points tested. Source data file: [Figure 1---figure supplement 1---source data 1](#SD2-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.005](10.7554/eLife.10747.005)10.7554/eLife.10747.006Figure 1---figure supplement 1---source data 1.Growth curves of wild type, *ssrA, ssrB* and D56A strains.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.006](10.7554/eLife.10747.006)10.7554/eLife.10747.007Figure 1---figure supplement 2.The planktonic sub-population of the *ssrB* strain was higher by two orders of magnitude compared to the wild type, *ssrA* and *D56A* strains at 2 days.n = 2, Mean ± SD, p \< 0.05. Source data file: [Figure 1---figure supplement 2---source data 1](#SD3-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.007](10.7554/eLife.10747.007)10.7554/eLife.10747.008Figure 1---figure supplement 2---source data 1.Number of cells in the planktonic sub-population of each strain.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.008](10.7554/eLife.10747.008)10.7554/eLife.10747.009Figure 1---figure supplement 3.Total wet weight of the adherent sub-population was decreased by at least 50% in the *ssrB* strain compared to the wild type, *ssrA* and D56A strains at 2 days.n = 2, Mean ± SD, p \< 0.05 for the *ssrB* strain versus *ssrA*/D56A strains and p = 0.08 for the *ssrB* strain versus wild type. Source data file: [Figure 1---figure supplement 3---source data 1](#SD4-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.009](10.7554/eLife.10747.009)10.7554/eLife.10747.010Figure 1---figure supplement 3---source data 1.Total wet weight of the adherent sub-population of each strain.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.010](10.7554/eLife.10747.010)

The ability to form biofilms was analysed for three strains, wild type 14028s, an *ssrA* null strain and an *ssrB* null strain, by observing appearance of the rough dry and red (rdar) morphotype on Congo Red plates. After seven days, each of the 14028s and *ssrA* mutant plates showed the appearance of rough, dry and red macrocolonies. However, the *ssrB* null strain exhibited a smooth, wet and pale brown morphotype which showed a poor ability to exhibit a multicellular phenotype ([Figure 1B](#fig1){ref-type="fig"}). The absence of Congo Red staining in the *ssrB* strain also indicated that there were greatly reduced levels of extracellular curli fibers in the macrocolony. These fibers form one of the key components of the extra-cellular matrix of a *Salmonella* biofilm. To examine the levels of cellulose, the other main component of the extra-cellular matrix, the three strains were grown on Calcofluor plates. The macrocolonies formed by 14028s and *ssrA* appeared white under UV, as cellulose binds the Calcofluor fluorescent dye ([Figure 1C](#fig1){ref-type="fig"}). The dull and non-white macrocolony produced by the *ssrB* null strain was starkly different, indicating again a poor extracellular matrix.

We visualized the nature of biofilms formed by the wild type and *ssrB* strains by Confocal Fluorescence Imaging of solid-surface biofilms formed under a continuous flow system in a micro-fluidic chamber. Wild type and the *ssrB* null strain were grown in minimal M9 medium and inoculated in their respective flow cells. After allowing the cells to attach for 1h, flow commenced and the growing biofilms were monitored daily for six days. Each day, the flow cell was removed, and the glass-attached cells were stained with SYTO-9 green, a fluorescent dye that stains nucleic acids. The cells were then imaged using fluorescence microscopy ([Figure 1D](#fig1){ref-type="fig"}). The figure clearly shows that for the wild type strain, the attached biomass not only increased progressively in size, but also in its complexity of design. This correlated with the appearance of typical mushroom-like constituent microcolonies by around 2 days. Such type of mature biofilms were never observed in the *ssrB* null strain and even after 6 days it failed to form biofilms, as evident by fewer and thinly attached clusters of SYTO-9 green-labeled cells.

To compare the differences in the structural properties of biofilms formed by the *ssrB* strain with the wild type and the *ssrA* mutant, cells were grown on APTES-coated cover slips in 16-well polystyrene microtiter plates for two days. The surface-attached communities were fixed, dehydrated and dried for Scanning Electron Microscopy (SEM). As expected, the wild type and *ssrA* mutant showed the presence of tightly knit communities of cells containing an extensive network of curli fibres surrounding large groups of cells ([Figure 1E](#fig1){ref-type="fig"}). In contrast, the *ssrB* null strain formed sparsely spaced groups of few cells with a large reduction in the surrounding matrix and poor network properties.

It was possible that the *ssrB* strain was just slower in biofilm formation and needed more time to exhibit its biofilm capability or that it caused a growth defect. We ruled out this possibility by measuring growth curves ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) and by monitoring the wild type and *ssrB* strains by crystal-violet staining every 12 hr for around 4 days. This determined that the *ssrB* mutant was not deficient for growth and remained incapable of forming biofilms up to 84 h, while the wild type formed large biofilms by 2 days ([Figure 1F](#fig1){ref-type="fig"}).

We next investigated the ability of *Salmonella* to form biofilms, on cholesterol-coated eppendorf tubes. The cholesterol-attached biofilms were estimated by crystal violet staining for the strains 14028s, *ssrA* null and *ssrB* null. There was a drastic reduction in the amount of biofilms formed by the *ssrB* strain on cholesterol-coated eppendorf tubes ([Figure 1G](#fig1){ref-type="fig"}). If cholesterol biofilms are indeed an indicator of an ability to form biofilms on gallstones ([@bib10]), then SsrB may be crucial for establishment of the carrier state in *Salmonella.*

Taken together, our results modify the initial hypothesis that SsrA was involved in the formation of biofilms. SsrB, but not its cognate kinase SsrA, is involved in the switch from planktonic growth to a multi-cellular lifestyle, in addition to its role in regulating genes required for pathogenesis.

Phosporylation of SsrB is not required for biofilm formation {#s2-2}
------------------------------------------------------------

Phospho-relay between the sensor kinase, SsrA, and the response regulator, SsrB, was crucial for activation of SPI-2 virulence genes ([@bib15]). SsrA is a tripartite sensor kinase that is presumably autophosphorylated by ATP at His405, followed by intra-molecular phosphorylation reactions at Asp739 and His867, based on homology to other tripartite kinases. His867 would then participate in the transfer reaction of the phosphoryl group to Asp56 in the N-terminus of SsrB. To confirm that SsrA-dependent phosphorylation was not required for SsrB-mediated regulation of biofilms ([Figure 1A--G](#fig1){ref-type="fig"}), we examined biofilm formation of *Salmonella* strains possessing H405Q, D739A and H867Q mutations in *ssrA* (Walthers and Kenney unpublished) and compared them to the wild type, *ssrA* and *ssrB* null mutants. Figure 3A indicates that the extent of biofilms formed by the three kinase point mutants was comparable to that of the wild type and the *ssrA* null mutant. A complete loss of *ssrB* was the only genetic change which adversely affected biofilm formation.

In the absence of SsrA kinase activity, small inorganic phosphate donors such as acetyl phosphate can phosphorylate SsrB, albeit with a lower efficiency ([@bib16]). We therefore constructed strains that were deficient in both SsrA kinase activity as well as in the production of acetyl phosphate and assayed their biofilm capabilities. Strains H405Q *ack pta*, D739A *ack pta* and H867Q *ack pta*, were all capable of biofilm formation ([Figure 2A](#fig2){ref-type="fig"}), demonstrating that none of the known phosphate donors for SsrB were required for regulating biofilms. In contrast, SPI-2 activation required *ssrA*, as measurement of β-galactosidase activity of a *sifA-lacZ* transcriptional fusion confirmed that activation of *sifA* required SsrA/B phosphorylation ([Figure 2C](#fig2){ref-type="fig"}).10.7554/eLife.10747.011Figure 2.Phosphorylation of SsrB is not required for biofilm formation.Amount of biofilms formed as measured by crystal violet staining for (**A**) Strains *ssrAH1, ssrAD, ssrAH2, ssrAH1AcP, ssrADAcP, ssrAH2AcP* and (**B**) D56A SsrB shows similar levels to that of the wild type, and higher than the *ssrB* mutant. Source data file: [Figure 2---source data 1](#SD5-data){ref-type="supplementary-material"}. (**C**) Beta-galactosidase activity of a *sifA-lacZ* chromosomal fusion was significantly lower in the *ssrB* null and the D56A SsrB mutant compared to the wild type. n = 3, Mean ± SD, p \< 0.0001. Source data file: [Figure 2---source data 2](#SD6-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.011](10.7554/eLife.10747.011)10.7554/eLife.10747.012Figure 2---source data 1.Source data for crystal violet staining in [Figure 2A and B](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.012](10.7554/eLife.10747.012)10.7554/eLife.10747.013Figure 2---source data 2.Source data for the measurement of beta-galactosidase activity in [Figure 2C](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.013](10.7554/eLife.10747.013)

SsrB is in the NarL subfamily of response regulators. NarL requires phosphorylation to relieve inhibition of C-terminal DNA binding by the N-terminus ([@bib2]). Therefore, we substituted the conserved Asp56 residue with Ala (D56A), and determined its ability to form biofilms ([Figure 2B](#fig2){ref-type="fig"}). The D56A strain was as competent as the wild type, *ssrA* null and *ssrA* kinase mutants in biofilm formation. The ability of unphosphorylated SsrB to regulate biofilm formation was unique, as it was unable to activate *sifA-lacZ* levels. The beta-galactosidase activity was significantly lower in the *ssrB* null and D56A strains (8.7% and 14.9%, respectively) compared to the wild type ([Figure 2C](#fig2){ref-type="fig"}). The D56A mutant was also able to form rdar macrocolonies on Congo Red plates. In addition, SEM imaging of D56A biofilms revealed that they maintained their intricate architecture and wild type structure (data not shown).

When cultures of the wild type, *ssrA, ssrB* and D56A strains were separated as a non-adherent (or free-swimming) sub-population and an adherent sub-population (or multicellular aggregates) ([@bib30]), we observed that the *ssrB* strain had a greater number of cells in the non-adherent fraction and fewer in the adherent fraction as compared to the other three strains. This confirms that the absence of SsrB, and not SsrB\~P, led to a defect in the ability of *Salmonella* to form surface-attached communities ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} and [3](#fig1s3){ref-type="fig"}).

Taken together, these results indicate that SsrB can activate biofilm formation in the absence of any phosphorylation signals. This is the first evidence for a role of unphosphorylated SsrB in gene regulation. These results also strongly advocate for a larger contribution of SsrB in *Salmonella* pathogenesis owing to its dual regulation of intracellular (i.e., the SCV) as well as mutli-cellular lifestyles (the carrier state).

SsrB-dependent biofilm formation does not require SPI-2 {#s2-3}
-------------------------------------------------------

SsrB is encoded on SPI-2 and regulates SPI-2 genes involved in assembly and function of the type three secretion system encoded by SPI-2, as well as effectors that are encoded on SPI-2 and outside of SPI-2 ([@bib16]; [@bib42]). To determine whether the SsrB target of biofilm regulation was dependent on the SPI-2 injectisome or any of its secreted SPI-2 effectors, we examined *ssaC* and *ssaJ* null strains for their ability to form biofilms ([Figure 3A](#fig3){ref-type="fig"}). SsaC is an outer ring component of the injectisome and SsaJ forms the inner ring of the SPI-2 needles. Both of these strains formed biofilms to an extent similar to the wild type and hence, we ruled out any involvement of the SPI-2 secretory apparatus or its related secreted proteins in the SsrB-dependent regulation of *Salmonella* biofilms.10.7554/eLife.10747.014Figure 3.SsrB regulates biofilms by a CsgD-dependent mechanism.(**A**) The SPI-2 needle, *ssaC* and *ssaJ* mutant strains were not affected in biofilm formation. (**B**) Over-expression of *csgD* from a plasmid (pBR328::csgD) *in trans* rescued biofilm formation in the *ssrB* mutant, as measured by crystal violet staining, n = 3. Source data file: [Figure 3---source data 1](#SD7-data){ref-type="supplementary-material"}. An estimate of *csgD* expression by (**C**) Real-time qRT-PCR showed a significant decrease in *csgD* transcription in the *ssrB* null, but not in the D56A SsrB and *ssrA* mutants. *rrsA* transcript levels were used as control; n = 2, Mean ± SD, p \< 0.0001. Source data file: [Figure 3---source data 2](#SD8-data){ref-type="supplementary-material"} and (**D**) Immunoblot analysis showing the absence of CsgD in the *ssrB* null strain in two day old biofilms, using GroEL as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.014](10.7554/eLife.10747.014)10.7554/eLife.10747.015Figure 3---source data 1.Source data for crystal violet staining in [Figure 3A and B](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.015](10.7554/eLife.10747.015)10.7554/eLife.10747.016Figure 3---source data 2.Source data for Real-time qRT-PCR in [Figure 3C](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.016](10.7554/eLife.10747.016)

Unphosphorylated SsrB activates *csgD* expression {#s2-4}
-------------------------------------------------

Biofilm formation in *Escherichia coli* and *Salmonella* Typhimurium is governed by the master regulator, CsgD, that acts as a transcriptional activator of genes involved in curli biogenesis and cellulose synthesis. Some of the environmental conditions that favor the formation of biofilms in *Salmonella* such as low salt and acidic pH also up-regulate levels of SsrB in the cell ([@bib15]). An obvious null hypothesis was therefore to test whether SsrB (in its unphosphorylated state), activated the expression of *csgD*. We first over-expressed *csgD* from a plasmid in the *ssrB* null mutant and determined whether it could rescue the defect in biofilm formation. The presence of *csgD* in *trans* restored the biofilm capability to wild type levels as measured by crystal-violet staining of 2 day old biofilms ([Figure 3B](#fig3){ref-type="fig"}).

We next examined the levels of *csgD* transcripts in 2 day macrocolonies formed by the wild type, *ssrA* null, *ssrB* null and D56A strains by quantitative real time RT-PCR (qRT-PCR). As shown in [Figure 3C](#fig3){ref-type="fig"}, there was around a 60-fold decrease in *csgD* transcripts when *ssrB* was deleted ([Figure 3C](#fig3){ref-type="fig"}). We also corroborated our previous findings ([Figure 1A](#fig1){ref-type="fig"} and [2B](#fig2){ref-type="fig"}), as *csgD* transcripts in the *ssrA* null and D56A strains were maintained at levels similar to the wild type. Furthermore, we probed the whole-cell lysates obtained from such macrocolonies with a monoclonal anti-CsgD antibody in order to measure the CsgD protein levels by western blotting. CsgD levels were undetected in the *ssrB* null compared to the wild type, *ssrA* null or D56A strains ([Figure 3D](#fig3){ref-type="fig"}). Hence, unphoshorylated SsrB was able to up-regulate the expression of *csgD* and positively influence the shift to a sessile lifestyle.

SsrB and H-NS differentially regulate *csgD* expression {#s2-5}
-------------------------------------------------------

Both in *E. coli* and *S.* Typhimurium, the expression of *csgD* is sensitive to various environmental stimuli such as starvation, temperature, pH and osmolality due to the action of upstream global regulators at the intergenic region of the *csgDEFG* and *csgBAC* operons. We noted that the SsrA/B system also responded to similar environmental conditions such as acidic pH and low osmolality. Furthermore, H-NS, a known repressor of SPI-2 genes ([@bib42]), was also known to regulate the expression of *csgD* in *E. coli* and *S.* Typhimurium ([@bib35]; [@bib18]). In regulating SPI-2 genes, SsrBc and H-NS work in an opposing fashion ([@bib43]). SsrBc antagonises the repressive action of H-NS at regulatory regions upstream of the promoters, while also acting as a direct transcriptional activator. We therefore examined whether or not this paradigm for SsrB-mediated transcriptional activation was applicable to *csgD* regulation.

In order to test this, we completely deleted *hns* from the *ssrB* null strain and determined if its deletion rescued biofilm formation. Crystal-violet staining of static biofilms formed by the wild type, *ssrB* and *ssrB hns* strains was performed; the amount of biofilms formed by *ssrB hns* was the same as the wild type. In contrast, the *ssrB* null strain remained at around 35% of these levels ([Figure 4A](#fig4){ref-type="fig"}). Macrocolonies formed by the *ssrB hns* strain also displayed a rugose morphology, reminiscent of the wild type strain after 2 days ([Figure 4B](#fig4){ref-type="fig"}). In addition, SEM images of 2 day-old biofilms formed by the *ssrB hns* strain showed a typical 'biofilm' architecture, i.e., densely packed communites of cells surrounded by biofilm matrix ([Figure 4C](#fig4){ref-type="fig"}). This result indicated that H-NS was functioning to repress *csgD* (see Discussion). Thus, we strengthened our prediction of a role for SsrB in the activation of *csgD* expression by acting as an anti-H-NS molecule.10.7554/eLife.10747.017Figure 4.*hns* deletion rescues biofilm formation in the *ssrB* mutant as shown by Crystal violet staining.(**A**) The amount of biofilms formed is higher in the wild type, *hns* and *ssrB hns* strains compared to the *ssrB* null, n = 3, Mean ± SD, p \< 0.0001. Source data file: [Figure 4---source data 1](#SD9-data){ref-type="supplementary-material"}. Macrocolony phenotype (**B**) *ssrB hns* forms a highly rugose and dry macrocolony, while the *ssrB* macrocolony was smooth and mucoidy. SEM imaging (**C**) *ssrB hns* biofilms were covered by a thick extra-cellular matrix; scale bar = 2 µm. (**D**) qRT-PCR: *csgD* levels were restored in the *ssrB hns* strain and were higher than the wild type (p \< 0.03) and the *ssrB* mutant (p \< 0.003) against *rrsA* transcripts as a control. Note that the normalized *csgD* levels in the *ssrB* null were 0.0009, too low for the scale. n = 2, Mean ± SD. Source data file: Source data file: [Figure 4---source data 2](#SD10-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.017](10.7554/eLife.10747.017)10.7554/eLife.10747.018Figure 4---source data 1.Source data for crystal violet staining in [Figure 4A](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.018](10.7554/eLife.10747.018)10.7554/eLife.10747.019Figure 4---source data 2.Source data for Real-time qRT-PCR in [Figure 4D](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.019](10.7554/eLife.10747.019)

We next examined the levels of *csgD* transcripts in mature biofilms formed by the wild type, *ssrB* null, *hns* null and *ssrB hns* null strains by qRT-PCR ([Figure 4D](#fig4){ref-type="fig"}). Normalized levels of *csgD* transcripts were highly up-regulated in the *ssrB hns* double mutant compared to the *ssrB* null strain, indicating that the loss of H-NS repression rescued the defect in *csgD* expression in the absence of SsrB. Expression of *csgD* was slightly higher than the wild type levels in the *hns* single mutant and the *ssrB hns* double mutant, which also correlated with their biofilm capabilities ([Figure 4A](#fig4){ref-type="fig"}). Since the levels of *csgD* transcripts were equal in the *hns* and *ssrB hns* null strains, it seemed likely that SsrB influenced *csgD* expression by silencing H-NS-mediated repression and not by direct activation of transcription, which requires phosphorylation for a productive interaction with RNA polymerase ([@bib43]).

Taken together, these results identified a regulatory role for unphosphorylated SsrB by orchestrating anti-silencing at the H-NS-repressed *csgD* locus. This work clearly shows that, as observed in *E. coli*, H-NS represses expression of *csgD* in *Salmonella* (see Discussion).

Unphosphorylated SsrB binds to the *csgD* regulatory region {#s2-6}
-----------------------------------------------------------

SsrB is a NarL family member and X-ray crystallography suggested that phosphorylation was required for DNA binding ([@bib2]). Thus, it was of interest to determine how SsrB relieved H-NS silencing at *csgD*. We used atomic force microscopy (AFM) to visualize the *csgDEFG-csgBAC* intergenic region and examined the effect of addition of full-length SsrB, D56A SsrB and SsrBc (DNA binding domain alone). Surprisingly, we observed binding of SsrB, D56A SsrB and SsrBc to distinct regions of the *csgD* regulatory region ([Figure 5B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1A and B](#fig5s1){ref-type="fig"}). Binding occured at low protein concentrations, suggesting high affinity interactions and showed that unphosphorylated SsrB was capable of binding *csgD*. An SsrB mutant, K179A, that was incapable of binding DNA ([@bib6]) did not bind *csgD* even at 300 nM, indicting that binding was specific ([Figure 5E and F](#fig5){ref-type="fig"}). Closer examination revealed a sharp curvature at the regions where SsrB was bound to *csgD* ([Figure 5B](#fig5){ref-type="fig"}, arrows). This result indicates that, like its NarL homologue ([@bib31]), SsrB bends DNA upon binding, as predicted ([@bib6]). We estimate that on average, binding of SsrB to the *csgDEFG-csgBAC* intergenic sequence occurred with a bending angle of around 82° ([Figure 5D](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"} for naked DNA). The observation that SsrB bending was more severe than NarL (82° compared to the 42° of NarLc at its cognate palindrome) ([@bib31]), likely contributes to its ability to promote anti-silencing.10.7554/eLife.10747.020Figure 5.SsrB binds upstream of *csgD*.(**A**) AFM images of the 755 bp *csgD* regulatory region (*csgD~755~*). (**B**) At 120 nM SsrB, distinct areas of SsrB binding were visualized as sharp bends (yellow arrows). (**C**) At 300 nM SsrB, areas of condensation (pink arrows) were observed. (**D**) Binding of SsrB bends the DNA by an average angle of 82º (for the naked DNA angle, refer to [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"} and for analysis refer to Supplementary method), Scale bar = 200 nm as in (**A**). (**E**) and (**F**) The SsrB mutant, K179A SsrB, which is defective in DNA binding, was unable to bind *csgD~755~* both at 30 nM or 300 nM; Scale bar = 200 nm.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.020](10.7554/eLife.10747.020)10.7554/eLife.10747.021Figure 5---figure supplement 1.AFM images of the 755 bp *csgD* regulatory region (*csgD~755~*) (**A**) with 120 nM D56ASsrB and (**B**) SsrBc.Distinct areas of binding were visualized as sharp bends (yellow arrows) and as areas of condensation (pink arrows) at 300 nM D56A SsrB (**C**) and SsrBc (**D**); Scale bar = 200 nm as in [Figure 5A](#fig5){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.021](10.7554/eLife.10747.021)10.7554/eLife.10747.022Figure 5---figure supplement 2.Bending angle of the naked *csgD~755~* fragment.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.022](10.7554/eLife.10747.022)10.7554/eLife.10747.023Figure 5---figure supplement 3.Electrophoretic mobility shift assay with the 122 bp *csgD* regulatory region, *csgD~122~*, showing a DNA-protein complex in the presence of SsrB.The K179A SsrB mutant did not bind to *csgD~122~*. Addition of competitor unlabelled *csgD~122~* fragment decreased the SsrB-DNA complex as apparent by an increase in free, labelled *csgD~122~*.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.023](10.7554/eLife.10747.023)

When the SsrB concentration was increased to 300 nM, we detected large-scale condensation of the DNA-protein complexes by AFM ([Figure 5C](#fig5){ref-type="fig"}). Condensation at the *csgD* regulatory region was similar when incubated with 300 nM D56A SsrB or SsrBc, indicating that protein binding led to DNA structural changes, irrespective of whether SsrB was phosphorylated ([Figure 5---figure supplement 1C and D](#fig5s1){ref-type="fig"}). Biochemical analysis of the protein-DNA complexes by an electrophoretic mobility shift assay using a shorter fagment of the *csgD* regulatory region ([Figure 6---figure supplement 4](#fig6s4){ref-type="fig"}), also indicated the presence of an SsrB-DNA complex. This complex was dissociated when an unlablelled *csgD* fragment was added as a competitor. In contrast, K179A SsrB failed to form a complex with DNA ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). The DNA bending ability of SsrB is important for SsrB relief of H-NS-mediated transcriptional silencing at *csgD* (see below and \[[@bib48]\]). The DNA binding behavior of SsrB was recapitulated in solution AFM imaging experiments, indicating that binding and condensation were not an artifact of drying the samples ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}).

SsrB binds an H-NS stiffened nucleoprotein filament at *csgD* {#s2-7}
-------------------------------------------------------------

Our previous work established that H-NS silenced genes by forming a rigid filament on DNA ([@bib28]; [@bib43]; [@bib27]). We purified H-NS, incubated it with the *csgD* regulatory region, and immobilised it on a glass coverslip. Subsequent AFM imaging indicated the presence of a straight and rigid nucleoprotein filament ([Figure 6A(i)](#fig6){ref-type="fig"}), which was distinct from the random conformation adopted by naked DNA ([Figure 5A](#fig5){ref-type="fig"}). Thus, we reaffirmed our earlier observations that H-NS repressed expression of *csgD* by filament formation, leading to transcriptional silencing ([Figure 4D](#fig4){ref-type="fig"}).

When we pre-formed stiffened filaments by addition of H-NS and then added SsrB, evidence of SsrB condensation was immediately apparent ([Figure 6A(ii)](#fig6){ref-type="fig"}). For example, areas of SsrB binding to DNA led to the formation of condensed nucleoprotein complexes and abolished the prior structural rigidity introduced by H-NS binding (see arrows, [Figure 6A(ii)](#fig6){ref-type="fig"}). Interestingly, [Figure 6A(ii)](#fig6){ref-type="fig"} also indicates that H-NS continued to form straight nucleoprotein complexes in regions devoid of SsrB (yellow line), i.e. H-NS was still bound to some regions of DNA when SsrB was also bound. Similar binding behavior with D56A SsrB and SsrBc at the H-NS-bound *csgD* regulatory region was also observed ([Figure 6---figure supplement 2A and B](#fig6s2){ref-type="fig"}), and similar binding patterns were observed in solution AFM ([Figure 6---figure supplement 1B--D](#fig6s1){ref-type="fig"}). This combined nucleoprotein complex was also detected as a supershift by electrophoretic mobility shift assay using a shorter fragment of the *csgD* regulatory region and specific concenterations of H-NS, SsrB and anti-SsrBc serum ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}). This *csgD* regulatory element harbored the H-NS binding region ([@bib18]) as well as an SsrB binding motif ([@bib16]; refer [Figure 6---figure supplement 4](#fig6s4){ref-type="fig"}). Thus, unphosphorylated SsrB can bind to the *csgD* regulatory region when it has been coated with the repressor H-NS. Anti-silencing results from SsrB-induced local topological changes in the DNA, in part as a result of its bending ability ([Figure 6B](#fig6){ref-type="fig"}). This likely provides enough free DNA to enable access to the promoter for RNA polymerase to activate transcription.10.7554/eLife.10747.024Figure 6.SsrB condenses H-NS bound *csgD* DNA.(**A**) (i) AFM imaging in the presence of 600 nM H-NS shows a straight and rigid filament on *csgD~755.~* (ii) Addition of 600 nM SsrB to the H-NS bound *csgD* DNA resulted in areas of condensation (pink arrows; an 'SsrB signature') along with a few areas where the straight H-NS bound conformation persisted (yellow line; an 'H-NS signature'); Scale bar = 200 nm as in [Figure 5A](#fig5){ref-type="fig"}. (**B**) A model for the mechanism of anti-silencing by SsrB at *csgD* wherein SsrB likely displaces H-NS from the ends of a stiffened nucleoprotein filament and relieves the blockade on the promoter for RNA polymerase to activate transcription. For details refer to ([@bib48]).**DOI:** [http://dx.doi.org/10.7554/eLife.10747.024](10.7554/eLife.10747.024)10.7554/eLife.10747.025Figure 6---figure supplement 1.Liquid AFM imaging of (**A**) the 755 bp *csgD* regulatory region.(**B**) In the presence of 600 nM H-NS, a straight and rigid filament was observed (yellow line). (**C**) In the presence of 300 nM SsrB, areas of condensation were evident (pink arrow). (**D**) Addition of 600 nM SsrB to the H-NS bound *csgD* DNA resulted in areas of condensation (pink arrows; an 'SsrB signature') along with a few areas where the straight H-NS bound conformation persisted (yellow line; an 'H-NS signature'); Scale bar = 200 nm.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.025](10.7554/eLife.10747.025)10.7554/eLife.10747.026Figure 6---figure supplement 2.SsrB D56A and SsrBc condense H-NS-bound *csgD* DNA.AFM imaging in the presence of H-NS shows areas of condensation upon addition of (**A**) 600 nM D56ASsrB and (**B**) 600 nM SsrBc; Scale bar = 200 nm as in [Figure 5A](#fig5){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.026](10.7554/eLife.10747.026)10.7554/eLife.10747.027Figure 6---figure supplement 3.SsrB and H-NS form a complex on *csgD*.Electrophoretic mobility shift assay with the 122 bp *csgD* regulatory region, *csgD~122~* (left to right); in the presence of SsrB and H-NS, the DNA-protein complex (\*) is super-shifted in the presence of anti-SsrBc serum (\*\*). A DNA-protein complex is also observed when SsrB and H-NS were present alone. Note the absence of any complex in a control reaction with *csgD~122~* and anti-SsrBc, while anti-SsrBc recognizes the SsrB-*csgD~122~* complex.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.027](10.7554/eLife.10747.027)10.7554/eLife.10747.028Figure 6---figure supplement 4.The sequence of the 755 bp *csgD* regulatory region indicating the H-NS binding region according to [@bib18]; and the SsrB binding motif as found by [@bib16].**DOI:** [http://dx.doi.org/10.7554/eLife.10747.028](10.7554/eLife.10747.028)

Discussion {#s3}
==========

Pathogenic microbes constantly evolve novel means to counter the multitude of challenges posed by complex eukaryotic hosts. Successful acquisition and integeration of laterally acquired genes into the native genome of pathogens leads to novel capabilities enabling their survival in a wide range of environmental stresses. The present work demonstrates how the presence or absence of the horizontally acquired SsrA kinase controls post-translational modification of the transcription factor SsrB (i.e. phosphorylation at aspartate-56). This event controls the fate of *Salmonella* Typhimurium, resulting in either acute or chronic, but asymptomatic infection. A variation on two-component signaling in a similar lifestyle fate in *Pseudomonas aeruginosa* involved the presence or absence of the hybrid kinase RetS ([@bib20]).

SsrB sits at a pivotal decision point that determines *Salmonella* lifestyles {#s3-1}
-----------------------------------------------------------------------------

When the SsrA kinase is present and activated by acid stress, SsrB is phosphorylated and SsrB\~P de-represses H-NS and activates transcription at SPI-2 and SPI-2 co-regulated genes, including: *sifA* ([@bib43]), *ssaB, ssaM, sseA* and *ssaG* ([@bib42]). In the absence of the SsrA kinase, SsrB is not phosphorylated, but it can counter H-NS silencing at *csgD* ([Figure 4A--D](#fig4){ref-type="fig"} and [Figure 6A](#fig6){ref-type="fig"}). SsrB binding and bending at the *csgD* promoter causes a sufficient change in the DNA secondary structure ([Figure 5B,C](#fig5){ref-type="fig"}) that likely enables access for RNA polymerase, stimulating *csgD* transcription. It is interesting to note that SsrB is located on the SPI-2 pathogenicity island, and thus was acquired as *Salmonella enterica* diverged from *Salmonella bongori*. However, the capability to form biofilms is an ancestral trait, as phylogeny studies have shown that most of the natural or clinical isolates of *Salmonella* belonging to all the five sub-groups form rdar colonies ([@bib45]). The SsrB response regulator can control two distinct lifestyle choices: the ability to assemble a type three secretory system and survive in the macrophage vacuole or the ability to form biofilms on gallstones in the gall bladder to establish the carrier state.

What then controls the presence or activation of the kinase SsrA? Our early experiments indicated that SsrA and SsrB were uncoupled from one another (i.e., SsrB was present in the absence of SsrA) and *ssrA* transcription was completely dependent on OmpR ([@bib16]). The EnvZ/OmpR system is stimulated by a decrease in cytoplasmic pH when *Salmonella* enters the macrophage vacuole ([@bib7]). This may also be the stimulus for activating SsrA, since the *Salmonella* cytoplasm acidifies to pH 5.6 during infection and the cytoplasmic domain of EnvZ (EnvZc) was sufficient for signal transduction ([@bib44]; [@bib7]). Previous reports also identified a role for PhoP in *ssrA* translation ([@bib3]), which would further add to fluctuating SsrA levels. The present work describes a novel role for the unphosphorylated response regulator SsrB in de-repressing H-NS ([Figure 6B](#fig6){ref-type="fig"}). We show that under biofilm-inducing conditions, unphosphorylated SsrB is sufficient to activate the expression of *csgD*. There are only a few such examples of unphosphorylated response regulators playing a role in transcription such as DegU ([@bib13]) in *Bacillus subtilis* and RcsB ([@bib24]) in *S.* Typhimurium.

The importance of anti-silencing in gene regulation {#s3-2}
---------------------------------------------------

In recent years, it has become apparent that H-NS silences pathogenicity island genes in *Salmonella* ([@bib29]; [@bib33]; [@bib42]; [@bib43]). Understanding how H-NS silences genes and how this silencing is relieved is an active area of research ([@bib47]; [@bib48]). Because the anti-silencing style of gene regulation is indirect and does not rely on specific DNA interactions, searching for SsrB binding sites has not been informative in uncovering this type of regulation ([@bib41]; [@bib49]; [@bib39]). Even a recent report in which the proteomes of wild type, *hilA* null (a transcriptional regulator of SPI-1 genes) and *ssrB* null were analyzed by SILAC and compared with an existing CHIP dataset failed to identify *csgD* as an SsrB-regulated locus ([@bib5]), as sequence gazing alone does not help in identifying mechanisms of transcriptional regulation.

SsrB is well suited to this style of regulation, because it does not recognize a well-defined binding site ([@bib16]; [@bib42]; [@bib41]), it has a high non-specific binding component ([@bib6]) and it bends DNA upon binding ([@bib6]; [Figure 6B](#fig6){ref-type="fig"}, this work). Furthermore, previous microarray studies disrupted both *ssrA* and *ssrB*, which would not uncover a distinct role for SsrB in gene regulation under non SPI-2-inducing conditions in the absence of the SsrA kinase. It is worth mentioning here that in our AFM images, it was apparent that H-NS was still bound to some regions of the *csgD* promoter when SsrB condensed the DNA ([Figure 6A(ii)](#fig6){ref-type="fig"}). Thus, H-NS does not have to be completely stripped off the DNA for de-repression to occur, a finding that was also evident in our previous studies ([@bib28]) and others ([@bib46]).

SsrB binds and bends DNA, resulting in highly curved DNA conformations. This DNA binding property of SsrB is distinct from H-NS, which forms rigid nucleoprotein filaments and thus straight DNA conformations ([Figure 6A(i)](#fig6){ref-type="fig"}). Bent DNA is therefore an energetically unfavorable substrate for H-NS binding, and a likely mechanism of SsrB-mediated anti-silencing of H-NS repressed genes. SsrB-dependent displacement of H-NS is more energetically favored to occur predominantly at the ends of H-NS-bound filaments, which requires disruption of fewer H-NS protein-protein interactions ([@bib48] and [Figure 6B](#fig6){ref-type="fig"}). In an equal mixture of H-NS and SsrB ([Figure 6A(ii)](#fig6){ref-type="fig"}), we do not see evidence of sharply bent filaments. This is expected because H-NS dissociation is likely restricted to the filament ends. Such events occur due to the cooperative nature of H-NS binding that results in a chain of linked H-NS proteins. Hence, H-NS displacement by SsrB likely occurs progressively from the filament end. This behavior has been observed in our single-molecule stretching experiments with H-NS filaments in the presence of SsrB. This ability of H-NS to re-orient on the DNA without being released would also promote its re-binding and silencing when SsrB or other anti-silencers are released ([Figure 6B](#fig6){ref-type="fig"}).

Structural homology does not indicate functional homology {#s3-3}
---------------------------------------------------------

Response regulators are grouped into subfamilies on the basis of the structures of their DNA binding domains. SsrB is in the NarL/FixJ subfamily, which possess a helix-turn-helix (HTH) motif in the C-terminus ([@bib2]). NarL was the first full-length structure of a response regulator and it showed that the N-terminal phosphorylation domain physically blocked the recognition helix in the HTH motif ([@bib31]). Thus, phosphorylation is required to relieve the inhibition of the N-terminus. In the results presented herein, it is apparent that SsrB has adapted to relieving H-NS-silencing and that phosphorylation is not required for this behavior, nor is it required for DNA binding ([Figure 5B](#fig5){ref-type="fig"}).

In summary, we showed that the response regulator SsrB is required for biofilm formation because it can de-repress H-NS at the *csgD* promoter ([Figure 6B](#fig6){ref-type="fig"}). This leads to the production of CsgD, the master regulator of biofilms. It is noteworthy that a laterally acquired gene product, SsrB, has evolved the job of regulating the levels of *csgD,* a transcriptional regulator encoded by the core genome. For this activity, phosphorylation of SsrB was not required, which is rare amongst response regulators. Furthermore, we identify H-NS as a repressor of *csgD* in *Salmonella*, instead of an activator ([@bib18]). This unifies the regulation of CsgD by H-NS in *E. coli* ([@bib35]) and *Salmonella*. This work places SsrB at a unique decision point in the choice between lifestyles by *Salmonella* and makes it crucial for the entire gamut of pathogenesis, i.e., biofilms and virulence.

Materials and methods {#s4}
=====================

Bacterial growth and media {#s4-1}
--------------------------

The bacterial strains and plasmids used in this study are listed in [Table 1](#tbl1){ref-type="table"}. *Salmonella enterica* serovar Typhimurium strains were grown in LB medium with shaking at 37°C in the presence of 100 μg/ml ampicillin, 12.5 μg/ml Tetracycline (Tet) or 50 μg/ml Kanamycin (Km) when necessary. For observing the rdar morphotype, plates of LB medium (without salt) containing 1% Tryptone and 0.5% Yeast Extract supplemented with congo red (40 μg/ml) (Sigma-Aldrich, Singapore) were prepared and kept at 30°C after inoculation. To detect cellulose production, LB without salt medium plates were supplemented with Fluorescent Brightener 28 (200 μg/ml) (Sigma-Aldrich), stored under darkness and observed under UV light after incubating at 30°C. For the SsrBc complementation test using the plasmid pKF104, 0.2% arabinose was added to the medium.10.7554/eLife.10747.029Table 1.List of Bacterial strains and plasmids.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.029](10.7554/eLife.10747.029)StrainDescription/NomenclatureReferencewild type*Salmonella enterica* serovar Typhimurium strain 14028sLab strain collection*ssrAssrA::TetRA* derivative of 14028sThis work*ssrB*DW85Don Walthers (originally from Stephen Libby)*ssaCssaC::TetRA* derivative of 14028s[@bib7]*ssaJssaJ::TetRA* derivative of 14028sHideaki Mizusaki unpublishedD56AD56A SsrB derivative of 14028sThis work*ssrAH1*DW748Don Walthers unpublished*ssrAD*DW749Don Walthers unpublished*ssrAH2*DW750This work*ssrAH1 sifA-LacZ*Made by transducing *sifA-lacZ* from DW636 to DW748This work*ssrAD sifA-lacZ*Made by transducing *sifA-lacZ* from DW636 to DW749This work*ssrAH2 sifA-lacZ*Made by transducing *sifA-lacZ* from DW636 to DW750Don Walthers; Lab strain collectionDW636*sifA-lacZ* at *attP* site in 14028sDon Walthers; Lab strain collectionDW637*ssrB::Km* derivative of DW636This work/Don Walthers (lab strain collection)*ssrAH1 AcPackA-pta::Km* (from DW142) transduced in DW748This work/Don Walthers (lab strain collection)*ssrAD AcPackA-pta::Km* (from DW142) transduced in DW749This work/Don Walthers (lab strain collection)ssrAH2 AcP*ackA-pta::Km* (from DW142) transduced in DW750This work/Don Walthers (lab strain collection)*hnshns::TetRA* derivative of DW636This work/Don Walthers (lab strain collection)*hns ssrBhns::TetRA* derivative of DW637This work/Don Walthers (lab strain collection)Plasmid pKF46D56A His-SsrB pMpM-A5Ω construct[@bib16]Plasmid pKF43His-SsrB pMpM-A5Ω construct[@bib16]Transformant DW160DH5α harboring His-HNS (*S. typhimurium*) in pMpM-A5Ω[@bib43]Plasmid pKF104His-SsrBc pMpM-A5Ω construct[@bib16]pBR328::csgD*csgD* constructProf Iñigo Lasa's groupPlasmid pRC24K179A His-SsrB pMpM-A5Ω construct[@bib6]

Molecular biology techniques {#s4-2}
----------------------------

All DNA manipulation procedures were carried out according to ([@bib38]) using reagents procured from Qiagen, Invitrogen or Fermentas, Singapore. Transformation in *S.* Typhimurium strains was performed by standard electroporation protocols ([@bib38]). Polymerase chain reaction (PCR) was carried out using oligonucleotides as listed in the [Table 2](#tbl2){ref-type="table"} following standard protocols ([@bib38]).10.7554/eLife.10747.030Table 2.List of oligonucleotides.**DOI:** [http://dx.doi.org/10.7554/eLife.10747.030](10.7554/eLife.10747.030)Purpose/nameSequence (5'-3')Digf (forward 755bp *csgD* regulatory region)tgatgaaactccactttttttaDigr (reverse 755bp *csgD* regulatory region)tgctgtcaccctggacctggtc*ssrA* knockout (forward)atgaatttgctcaatctcaagaatacgctgcaaacatctt ttaagacccactttcacatt*ssrA* knockout (reverse)agccgatacggcattttcaatatcagccagcaagaggtcc ctaagcacttgtctcctgcsg1 (forward *csgD* internal)ggaagatatctcggccggttgccsg2 (reverse *csgD* internal)tcagcctagggataatcgtcagrrsA1 (forward *rrsA* internal)gcaccggctaactccgtgccrrsA2 (reverse *rrsA* internal)gcagttcccaggttgagcccgPSsrBF (forward for pKF46)atgaaagaatataagatcttatPSsrBTR (hybrid reverse for pKF46)ttaatactctaattaacctcattcttcgggcacagttaagtctaagcacttgtctcctgTSsrBF (forward TetRA-*ssrB*)acttaactgtgcccgaagaatgaggttaatagagtattaattaagacccactttcacattTSsrBR (reverse TetRA- after *ssrB* stop)catcaaaatatgaccaatgcttaataccatcggacgcccctggctaagcacttgtctcctgDigb (Forward for EMSA)Biotin- tgatgaaactccactttttttaCsgDigRS (Reverse for EMSA)aatatttttctctttctggata*hns* knockout (forward)gctcaacaaaccaccccaatataagtttggattactacattaagacccactttcacatt*hns* knockout (reverse)atcccgccagcggcgggattttaagcatccaggaagtaaactaagcacttgtctcctg

Strain construction {#s4-3}
-------------------

The *S.* Typhimurium strain harboring a D56A mutation in SsrB was generated by the homologous recombination technique as decribed in ([@bib23]). Plasmid pKF46 ([@bib16]) was used to construct the necessary linear DNA fragment by a two-step overlapping PCR ([@bib38]). Homologous recombination was also used to construct the *hns* and *ssrA* deletion mutants in the respective strain backgrounds. The *sifA-lacZ* marker was transduced into the lambda *attP* site of strains DW748 (ssrAH1), DW749 (ssrAD) and DW750 (ssrAH2) using standard P22 transduction protocols ([@bib14]).

Fluorescence confocal imaging of flow cell biofilms {#s4-4}
---------------------------------------------------

Biofilms were grown in three-channel glass-bottomed flow cells (individual cell dimensions 1 × 4 × 40 mm^3^) with an individual-channel flow rate of 8 ml/h of 0.5X M9 glucose minimal medium. Each channel was inoculated with M9 minimal medium cultures adjusted to an OD~600~ of 0.04. Flow was started after allowing initial attachment for 1 hr. After specific time points, each channel of the flow cell was stained with 200 μl SYTO-9 green (Invitrogen, Singapore) as per the manufacturer's protocol. Subsequently, for each flow cell channel image acquisition was performed using a LSM 780 Carl Zeiss confocal fluorescence microscope at 480/500 nm (20X magnification). Five image stacks were acquired starting from the center of the channel to a distance of 5--10 mm from the inlet, approximately 5 mm apart. This experiment was repeated twice in duplicates for the wild type and *ssrB* mutant strains. All images were processed using the Image J software.

Scanning electron microscopy (SEM) {#s4-5}
----------------------------------

Static biofilms were grown by inoculating the bacterial strains on APTES-coated coverslips in 24-well Nunclon polystyrene plates in 500 μl LB without salt medium and kept shaking at 30°C, 100 rpm. After two days, the growth medium was removed; wells were washed with PBS and incubated with 200 μl of the fixative solution (4% para-formaldehyde+0.2% glutaraldehyde in filter-sterilized PBS) for 1 hr at room temperature. After washing twice with sterile water, 35%, 50%, 75%, 90%, 95% and 100% ethanol were added sequentially and kept for 10 min at room temperature. Dehydrated samples were stored in absolute ethanol and kept at 4°C until subjected to critical point drying. Images were obtained using a Carl Zeiss Merlin field emission scanning electron microscope by detecting secondary electrons (SE2) under low electron beam acceleration voltage (1 kV) and low probe current (76 pA).

Crystal violet staining {#s4-6}
-----------------------

To estimate the amount of biofilms typically a single colony was inoculated in LB broth medium and incubated at 37°C/250 rpm. 2 μl of this culture was added to 198 μl LB without salt medium in a 96-well polystyrene plate and kept at 30°C with gentle shaking of 100 rpm. After two days, the growth medium was removed and each well was washed twice with 200 μl of Phosphate-buffered Saline (PBS). The attached bacterial communities or biofilms in each well were then stained with 200 μl crystal-violet solution (0.1%) for a minimum of 1 min. This was followed by washing twice with PBS and addition of 200 μl absolute ethanol. Appropriate dilutions were measured for absorbance at 580 nm using a Tecan Infinite M200 plate reader. Each experiment was performed at least thrice in triplicates. For the time course experiment, the above procedure was performed twice at 12, 24, 36, 47, 60, 72 and 84 hr respectively in triplicates.

Tube biofilm assay (TBA) {#s4-7}
------------------------

To study the capability of the *Salmonella* strains to form biofilms on cholesterol-attached surfaces, a tube biofilm assay was performed as described in ([@bib10]), but without the use of bile salts in the growth medium. LB without salt medium was used for growth at all steps. All experiments were performed at least thrice in triplicates for 7 days on a nutator shaker at room temperature. Biofilms formed at the end of seven days were estimated using the above described crystal violet staining protocol with appropriate controls.

Beta-galactosidase assay {#s4-8}
------------------------

Each of the bacterial strains were grown overnight in LB, washed twice and resuspended in 50 μl of PBS buffer. These were then transferred into 1 ml of fresh MgM medium, pH 5.7, as in ([@bib15]) and kept shaking at 37°C for around 6--7 h, until growth reached OD~600~ between 0.6--0.8. At this stage, 50 μl of the culture was removed in a 96-well microtiter plate and 145 μl of lysis buffer was added (0.01% SDS, 50 mM Beta Mercaptoethanol in Z-buffer) as performed previously ([@bib15]). The β-galactosidase activity was represented in Miller Units and calculated as 1000 x \[(OD~420~-1.75 x OD~550~)\]/ t (min) x volume (ml) x OD~600~). Measurements were made in a Tecan Infinite M200 plate reader and repeated thrice in triplicates.

RNA isolation {#s4-9}
-------------

Total RNA was isolated from two-day old macrocolonies using the Qiagen RNeasy kit (Qiagen, Singapore) as per the manufacturer's protocol with some modifications. Briefly, the macrocolonies were selected and re-suspended in 1 ml Qiagen RNAprotect reagent followed by immediate total RNA isolation or storage at -80°C. Appropriate volume of lysis buffer, 15 mg/ml lysozyme in TE buffer, was used. After dissolving the RNA in 20 μl RNase-free water, samples were assessed by gel electrophoresis and quantified using the Nanodrop system (THERMO Scientific, Singapore). All RNA samples were treated with TURBO DNase as per the manufacturer's protocol (Life Technologies, Singapore). PCR analysis using *rrsA* specific primers was performed to ensure the absence of genomic DNA in the RNA preparations.

Reverse transcription and quantitative real-time PCR {#s4-10}
----------------------------------------------------

Reverse transcription reaction was carried out using the iScript reverse transcription supermix for RT-qPCR (BIO-RAD, Singapore) according to the recommended protocol. This was followed by amplifying 5--10 ng cDNA by real-time qPCR using SsoFast EvaGreen Supermix (BIO-RAD) and *csgD*-specific primers. Similar reactions were set up using *rrsA*-specific primers for their use as normalization controls. All experiments were performed in triplicate with two independent RNA preparations. Relative transcript abundance was determined using the △C~T~ method using a reference gene as per the manufacturer's guide.

Immunoblot analysis {#s4-11}
-------------------

Two-day old macrocolonies were resuspended in 400 μl Laemmli buffer ([@bib38]) and total protein was separated by 10% SDS-PAGE. This was followed by electro-transfer to a PVDF membrane as described before ([@bib16]). The membrane was incubated with anti-CsgD (1:10,000) or anti-GroEL (1:5000) antibodies in PBS buffer containing 0.05% Tween-20 and 3% BSA. Anti-rabbit secondary antibody (Santa Cruz Biotechnology Inc., Dallas, TX) was used for detection as described previously ([@bib16]).

Overexpression and purification of proteins {#s4-12}
-------------------------------------------

The *E. coli* BL21 (DE3) strain was used as a host for the overproduction of proteins His-SsrBc, His-SsrB, D56A His-SsrB, K179A His-SsrB and His-H-NS. The respective plasmids harboring the constructs have been listed in Supplementary [Table 2](#tbl2){ref-type="table"}. Detailed procedures for the purification of His-SsrBc, His-SsrB, D56A His-SsrB and K179A His-SsrB have been described before ([@bib16]; [@bib42]; [@bib6]). The DW160 plasmid harboring His-tagged H-NS from *Salmonella* Typhimurium was used to overexpress and purify His-H-NS following the procedure described in ([@bib43]).

Atomic force microscopy (AFM) {#s4-13}
-----------------------------

Glutaraldehyde-modified mica surface was prepared as decribed previously in ([@bib28]) and references therein. A 755 bp sequence upstream to the +1 start site ([@bib18]) of *csgD* was amplified and gel purified. This fragment also harbored a SsrB-specific site ([@bib16]; [@bib42]), TTATAAT sequence ([Figure 6---figure supplement 4](#fig6s4){ref-type="fig"}). A typical 50 μl reaction contained 10 ng of this DNA (755 bp of the *csgD* regulatory region) mixed with an appropriate amount of SsrB, SsrBc or D56A SsrB and incubated for 15 min at room temperature. This mixture was then deposited on glutaraldehyde-modified mica for 15 min. Images were acquired on a Bruker Dimension FastScan AFM system using the tapping mode with a silicon nitride cantilever (FastScan C, Bruker). Raw AFM images were processed using Gwyddion software (<http://gwyddion.net/>). The bending angle was analysed using a home-written Matlab code as described in the Supplementary methods.

Statistical analysis {#s4-14}
--------------------

GraphPad Prism 6 version 6.00, GraphPad Software, La Jolla California, www.graphpad.com was used to make all the graphs and do statistical analysis by Student's t-test wherever required.

Suplementary methods {#s4-15}
--------------------

### Growth curves (Total viable count) {#s4-15-1}

*Salmonella enterica* serovar Typhimurium strains were grown in LB medium overnight from single colonies at 37°C/250 rpm. 1% of starting cultures were added to LB (without salt) medium containing 1% Tryptone and 0.5% Yeast Extract and incubated shaking at 37°C/100 rpm in 14 ml tubes. At every 2 hr, an aliquot from the culture was removed, diluted appropriately and plated on LB agar plates. The number of colonies formed after incubation at 37°C were counted and growth curves were plotted.

### Estimation of adherent and non-adherent sub-populations {#s4-15-2}

*Salmonella enterica* serovar Typhimurium strains were grown in 50 ml 1% Tryptone medium in 250 ml flasks and kept shaking at 28°C/200 rpm ([@bib30]). After 2 days, the entire 50 ml culture was transferred in 50 ml falcon tubes, including the aggregates that have attached to the wall of the flask, and was centrifuged at 210 rpm/2 min. Appropriate dilutions from the supernatant or the non-adherent (free-swimming) fraction were plated on LB agar plates for enumeration. Total wet weight of the pellet or the adherent (multicellular) fraction was determined after a brief centrifugation at 10,000 rpm for 1 min.

### Electrophoretic mobility super shift assay {#s4-15-3}

Electrophoretic mobility assay using the LightShift Chemiluminescent EMSA kit (THERMO Scientific) was modified to detect complexes formed by the binding of SsrB and/or H-NS to the *csgD* regulatory region. A 5'-biotinylated *csgD* DNA fragment was prepared by amplifying the upstream regulatory region of *csgD* (122bp) using respective primers from the wild type strain 14028s. 5 fmol of this probe was then incubated with 1.08 μM SsrB/K179A SsrB or 15 μM H-NS in a binding buffer containing 10 mM Tris, pH 7.5; 50 mM KCl, 2.5% glycerol; 0.05% Nonidet P-40 and 1 μg poly (dI-dC), for 20 min at RT. In case where competitor DNA was added, a 200-fold excess of an unlablelled *csgD~122~* was first incubated with 1.08 μM SsrB for 20 min, followed by the addition of 5 fmol labelled probe to the reaction buffer and subsequent incubation for 20 min. For detecting a supershift, 1.08 μM SsrB and 15 μM H-NS were incubated with 0.5 μl anti-SsrBc serum in the binding buffer for 1 hr at RT. 5 fmol of the probe was then added and incubated for additional 20 min at RT. The reactions were subsequently subjected to electrophoresis, electro-blotting, cross-linking and detection as described previously ([@bib6]).

### Measurement of the bending angle ([Figure 7](#fig7){ref-type="fig"}). {#s4-15-4}

![DNA tracing and bending angle measurement.\
(****A****) The original AFM image as processed with the Gwyddion software. (****B****) A Matlab code was used to trace the DNA in the AFM images. The digitized binary line represents the DNA backbone (red line), with the two end points marked by green dots. (****C****) For the bending angle measurement, a point along the red line was manually selected as the binding location of SsrB on DNA (green asterisk). The red asterisks indicate two points that are 15 nm upstream and downstream from this protein-binding site. Linear interpolation of points scattered along the green and red asterisk was used to plot a straight line between these points (yellow line). The angle between the yellow lines (α) is determined as the bending angle of SsrB; 81 such measurements were made. The same procedure was followed for the control AFM images of *csgD~755~*, 327 such measurements were made.\
**DOI:** [http://dx.doi.org/10.7554/eLife.10747.031](10.7554/eLife.10747.031)](elife-10747-fig7){#fig7}

### Liquid atomic force microscopy (AFM) {#s4-15-5}

Glutaraldehyde-modified mica surface was prepared as decribed previously in ([@bib28]) and references therein. A 755 bp sequence upstream to the +1 start site ([@bib18]) of *csgD* was amplified and gel purified. This fragment also harbored a SsrB-specific site ([@bib16]; [@bib42]), TTATAAT sequence ([Figure 6---figure supplement 4](#fig6s4){ref-type="fig"}). A typical 50 μl reaction contained 10 ng of this DNA (755 bp of the *csgD* regulatory region) mixed with an appropriate amount of SsrB or H-NS and incubated for 15 min at room temperature. This mixture was then deposited on glutaraldehyde-modified mica for 15 min. Images were acquired on a Bruker Dimension FastScan AFM system using the tapping mode with a silicon nitride cantilever (FastScan C, Bruker). Raw AFM images were processed using Gwyddion software.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"To P or not to P a role for unphosphorylated SsrB in activating *csgD (agfD*) to regulate *Salmonella* Typhimurium biofilms\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Richard Losick as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

This is an interesting paper that describes an unexpected role for a *Salmonella* response regulator in a two-component regulatory system. The authors conclude that the response regulator SsrB has a gene regulatory function in addition to its established role in accepting phosphate from SsrA to activate so-called SPI-2 genes important for virulence. In an SsrA-independent manner SsrB derepresses transcription of *csgD*, which itself serves as a transcription activator of genes required for biofilm formation. In this way SsrB can serve as a decision point between the planktonic and biofilm lifestyles this bacterium has in colonized hosts. The manuscript shows that *csgD* activation involves unphosphorylated SsrB. Evidence is consistent with the idea that HNS binds the *csgD* promoter region and this silences or represses *csgD* expression. Unphosphorylated SsrB derepresses *csgD* not by binding HNS but by binding to the *csgD* promoter itself and occluding some of the HNS binding.

The reviewers believe that several modifications to the manuscript are needed prior to acceptance:

The title needs to be changed. The manuscript needs to be condensed. Some specific suggestions are provided in the detailed reviewer comments. There is thought that [Figure 1](#fig1){ref-type="fig"} is not relevant. Reviewer 2 has some specific concerns about [Figure 2](#fig2){ref-type="fig"}, [4](#fig4){ref-type="fig"} and [6](#fig6){ref-type="fig"} that require some attention and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} requires additional controls. There is some concern about whether the artificial in vitro systems reflect the native situation. Some caution about interpretation is advised.

Reviewer 3 would like to see additional biofilm data, \"It is therefore necessary to somehow quantify the entire population of Salmonellae in the tube and assess what fraction of it adheres. A true biofilm-defective mutant should show a shift from a fraction that adhere to the non-adhering planktonic population.\" Finally, Reviewer 3 points out that, \"The elegant experiments using AFM need to be supported with certain controls, primarily aimed at demonstrating specificity of binding of SsrB to the *csgD* regulatory region (and lack of binding to other H-NS silenced regions) in both AFM and electrophoretic mobility shift assays.

*Reviewer \#1:*

This is an interesting paper that describes an unexpected role for a *Salmonella* response regulator in a two-component regulatory system. The paper shows that the response regulator SsrB has a gene regulatory function in addition to its established role in accepting phosphate from SsrA to activate so-called SPI-2 genes important for virulence. In an SsrA-independent manner SsrB derepresses transcription of *csgD*, which itself serves as a transcription activator of genes required for biofilm formation. In this way SsrB serves as the decision point between the planktonic and biofilm lifestyles this bacterium has in colonized hosts. The manuscript shows that *csgD* activation involves unphosphorylated SsrB. It shows that HNS binds the *csgD* promoter region and this silences or represses *csgD* expression. Unphosphorylated SsrB derepresses *csgD* not by binding HNS but by binding to the *csgD* promoter itself and occluding some of the HNS binding. This was shown by AFM of single molecule binding to DNA. The microscopy is well suited for *eLife* publication.

The work is interesting in a number of aspects. It points to novel ways in which response regulator components of two-component regulatory systems can function. It explains for the case of one of the still rare examples where an unphosphorylated response regulator can function how it does so. It addresses the issue of the important lifestyle \"decision\" that *Salmonella* makes. It also provides insight about HNS silencing and how anti-silencing can occur. This is a current area of interest with respect to evolution of bacterial pathogens.

There are several issues with the manuscript that the authors need to address. I present them here in the order in which they arise in the manuscript.

1\) Title. \"To P or not to P\" conveys little information and might be appropriate for the Insight published along with the article. The rest of the title will make sense only to those working in the field. I would suggest something along the lines of \"An unphosphorylated two-component response regulator induces *Salmonella* Typhimurium biofilm genes by antisilencing a biofilm master-regulator gene.\"

2\) Key words. I think key words are meant to exclude words already appearing in a title.

3\) Abstract. Delete \"Remarkably.\" There is an overuse of emphasis words in general in the manuscript. I find this quite distracting. \"Highly upregulated\", unequivocally rule out, \"Sharp contrast\", etc. These all seem like overstatements to me.

4\) The Introduction is very long. It reads like the introduction to a thesis. I am not sure what might be condensed but it would be helpful to condense if possible.

5\) Introduction, fourth paragraph. Delete \"Walthers and Kenny unpublished.\" It is not something the reader can refer to as are the publications referenced.

6\) Last two paragraphs of the Introduction. As written it is confusing as to what the authors showed previously and what they are showing in this manuscript.

7\) Subsection "Unphosphorylated SsrB activates biofilm formation". I think the interpretations should be recast. First we learn that SsrA is not required for the biofilm phenotype. So it could be unphosphorylated B or B could be phosphorylated by an alternate donor. Then we learn that general donors like acetyl-P are not involved. So it could be unphosphorylated or there could be some sort of unknown cross talk with another sensor kinase. Finally we learn that Asp56, the residue phosphorylated by SsrA, can be mutated to an alanine and the protein still functions with respect to biofilm formation (but not SPI2 gene activation). This is good genetic evidence that the protein induces biofilm formation in an unphosphorylated form.

8\) Subsection "Unphosphorylated SsrB activates biofilm formation". This is an example of a sentence that needs rewriting. \"To confirm our hypothesis we examined...\". This is not the scientific method. Experiments are meant to be designed to disprove one's hypothesis. A simple wording change would provide a fix, for example: \"To test our hypothesis...\". This wording problem comes up in a few other places as well.

9\) Subsection "Unphosphorylated SsrB activates biofilm formation". Change \"This is the first evidence\" to \"This provides evidence that\".

10\) Subsection "SsrB and H-NS differentially regulate *csgD* expression", third paragraph. I am missing something here. I don\'t understand why the hypothesis explains why phosphorylation was not required.

11\) Subsection "SsrB binds an H-NS stiffened nucleoprotein filament at *csgD*". The last sentences seem to describe a model based on the evidence presented rather than a proven mechanism and should be presented in this way. Particularly for the last sentence on RNAP I see no evidence in the manuscript.

12\) Subsection "SsrB sits at a pivotal decision point that determines *Salmonella* lifestyles", first paragraph and elsewhere. \"It can de-repress HN-S at *csgD*\" seems like confusing jargon to me. Do the authors mean \"it can counter HN-S repression of *csgD*\" or \"counter HN-S silencing of"?

13\) Subsection "SsrB sits at a pivotal decision point that determines *Salmonella* lifestyles". Again I did not see any experiments about enabling access of RNAP. This seems logical but it should be presented as a model.

14\) The model is presented as a counterpoint to the idea that periplasmic histidines can play a role (\"we think this is unlikely\"). I got a little confused here about whether maybe both things could be true. Are they mutually exclusive?

15)"It is worth mentioning here that in our AFM images, it was apparent that H-NS was still bound to some regions of the *csgD* promoter when SsrB is condensing the DNA ([Figure 6A](#fig6){ref-type="fig"}(ii))". There is a mixture of tenses. I would change \"when SsrB is condensing\" to \"was condensing.\"

16\) It seems like the whole first paragraph of the subsection "Structural homology does not indicate functional homology "could be deleted. I am not engaged by the fact that \"we were lulled into thinking that SsrB would behave like NarL.\" There are examples of transcriptional regulator families where some members require ligand binding to bind DNA and activate genes. They do this in the same way that NarL interacts with P to expose the DNA binding motif. Other members of the same family bind DNA and repress genes in the absence of ligand. The ligand blocks DNA binding.

The last half of the last paragraph of the Discussion is maybe the fourth or fifth time the authors bring up the fact that their conclusion that HNS represses or silences *csgD* conflicts with the conclusion of Gerstal. Although this may be true, the way it is presented is not constructive. First, I believe this point should not be raised in the Results (as it is now). It is a point of discussion. Second, I don\'t think, as it stands, it corrects the scientific record. If the authors want to discuss this they should make some attempt to resolve the conflict. Why do they think they arrived at a conclusion opposing that of Gerstel et al.? Are there strain differences? Did Gesrtel misinterpret or over-interpret a result? If the authors want to put any focus on the different conclusions then they should try to help us understand what might be a possibility. It is ok to say something about how at least with our strains and experimental protocols we find HNS silencing of *csgD* whereas Gerstel using a different whatever found HNS activation or whatever it is. It takes a level of brio to just claim ones results are more believable than others.

*Reviewer \#2:*

In this manuscript the authors build on previous work demonstrating that the SsrAB regulators are important to *Salmonella* typhimurium biofilm formation. They determine that the SsrA histidine kinase is not required, but that the SsrB response regulator is required for biofilm formation as measured using methylene blue staining, Congo Red, and Calcofluor plates. They then analyzed the colonies formed in a microfluidic chamber in M9 medium in a flow cell and in cholesterol coated eppendorf tubes to further substantiate the biofilm phenotype. The authors provide support for the lack of phosphorylation of SsrB being what is necessary for SPI2 regulation of curli genes responsible for biofilms by using SsrB phosphorylation deficient bacteria, with mutations in SsrA and the ability to produce acetyl phosphate. The requirement of SsrB to form biofilms was repressed by deletion of H-NS providing in vivo evidence that SsrB could act by competing or silencing H-NS based repression. The authors then provide evidence that SsrB/HNS bind to the Csg promoter responsible for the synthesis of curli. The results add to our knowledge of *Salmonellae* gene regulation of biofilm formation, but do not really define where and how this may occur in vivo and/or what specific environmental conditions would lead to activation but not phosphorylation of SsrB.

Specific comments:

A great deal of data was not shown and this should be corrected prior to publication.

Throughout the manuscript the authors claim that they showed different results than that shown in Hamilton et al. However in this work the effect of an ssrA mutant on biofilm formation was complemented with a plasmid encoding both ssrA and ssrB. Therefore the results are likely a result of mutation of both genes or polarity. Therefore the results are really similar and the authors have provided molecular detail as to the mechanism.

Since most of the paper is about mechanisms of transcription that lead to biofilm formation I am not sure what [Figure 1](#fig1){ref-type="fig"} adds to the manuscript.

In [Figure 2D](#fig2){ref-type="fig"} the staining seems the same at 6 days. This is a surprising result, has the biofilm been formed that rapidly by another sensing mechanism?

In [Figure 2F](#fig2){ref-type="fig"} why does the increase at later time points occur and why is it greater at 36 hours than at 47 and 69 hours? How many replicated experiments are represented by the figure and are the statistical analyses significant? This is not commented on in the figure legend.

The phenotype of the *ssrA* mutant should be shown in [Figure 2B-D](#fig2){ref-type="fig"}.

The higher migrating signal in the western blot in [Figure 4D](#fig4){ref-type="fig"} is said to be non-specific in the figure legend. However, It is not present to a very great degree in the wild type and is greater in the *SseA* and D56A mutant and absent in *ssrB* mutants. What is this band and does it indicate another larger form of CsgD or has a different promoter been utilized when non-phosphorylated SsrB is present? This band should be isolated and protein sequenced to define its nature.

What is the evidence that the binding angle observed in vitro with an artificial substrate by ATM reflects its ability to promote anti-silencing (subsection "Unphosphorylated SsrB binds to the *csgD* regulatory region", first paragraph)?

Again condensation on a silica binding substrate of a regulatory region on an increase of concentration of the protein that binds may or may not be biologically relevant in vivo (subsection "Unphosphorylated SsrB binds to the *csgD* regulatory region", last paragraph). The authors should reduce this speculation and consider performing the AFM in solution and under helium rather than nitrogen and see if similar results are obtained.

The fact that HNS alters structure of DNA on a solid support does not reaffirm more than the biological data the mechanism by which HNS represses transcription, it just indicates under these conditions in binds to the DNA (subsection "SsrB binds an H-NS stiffened nucleoprotein filament at *csgD*", first paragraph).

I think the data support a model in which SsrB alters the bending of DNA, though it seems this may not be a direct effect in vivo and the authors should soften the statement that they have identified the mechanism by which unphosphorylated SsrB regulates *csgD*.

I am not sure the authors are correct in their ideas about SsrB function controlling extracellular lifestyle of *Salmonellae* since there are many growth conditions in which ssrAB are not expressed and the bacteria can form biofilms. Hence this may be most important for the expression of a biofilm under certain conditions of SPI2 expression but not SsrA activation as a kinase. This may actually occur inside host cells and recent evidence of cellulose expression in host cells and past work showing curli biosynthesis genes can be regulated by RpoS may suggest that they are expressed inside of host cells and hence the authors results may be most relevant to how curli may be expressed inside of host cells rather than SsrAB being another host switch more like PhoPQ.

The title contains this "to P or not to P", which I found confusing and relatively unscientific since it does not represent PO4. This should probably be changed prior to publication.

In [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}, why is so little shifting seen with SsrB in the absence of HNS? Is the affinity very low? Additional controls should include SsrB without the anti-ssrB antibody that causes the super shift. Is no binding seen without HNS? If the AFM is significant, binding should be seen without HNS present.

The data would be strengthened by footprinting and defining the specific promotor sequences bound by SsrB and H-NS prior to publication.

Reviewer \#3:

The authors present a series of experiments demonstrating a novel role for a two component regulatory system, implicated in the virulence and persistence of *Salmonella enterica*. The main novel aspects of the findings described in the manuscript are: 1) Demonstration that the SsrB response regulator is a molecular switch, reciprocally controlling two sets of traits associated with virulence (the expression of a type III secretion system) and biofilm formation; 2) Defining an active function for an un-phosphorylated response regulator; 3) Elucidation of a novel regulatory mechanism for a response regulator activity (anti-silencing) by DNA bending and 4) Evolutionary implications for acquisition of a regulatory system by horizontal gene transfer, controlling the expression of core, chromosomal genes.

Overall, this paper contains substantial amount of new results (in quality and in quantity) and represents information with broad interest to those readers who are interested in new molecular mechanisms of gene regulation, strategies of pathogenic organism capable of causing acute and chronic infections and their evolution. This is important work, established a new paradigm for two-component signaling. The only concern is with a few technical points related to certain experiments and a need for a few additional controls.

*Reviewer \#3 (Minor comments):*

There are a few minor issue that the authors should address, mainly to make the manuscript more readable and highlighting its strongest points.

1\) There is excessive amount of data on attempts to demonstrate that the absence of SsrB has an effect on biofilm formation. That could be simply reduced to a single figure comparing *ssrB* deletion with point mutants in SsrA and SsrB.

2\) The major biofilm assay used in this work is based on adherence of bacteria to the sides of polystyrene tubes. This method actually measures only adhesion of the bacteria to their biofilm phenotype. A simple growth defect of the *ssrB* mutant would be also reflected as a decrease in adherence and erroneously concluded as a defect in biofilm formation. It is therefore necessary to somehow quantify the entire population of *Salmonellae* in the tube and assess what fraction of it adheres. A true biofilm-defective mutants should show a shift from a fraction that adhere to the non-adhering planktonic population.

3\) [Figure 4D](#fig4){ref-type="fig"} is rather un-convincing; the lane containing the D56A mutant indicates some problems with transfer of CsgD from gels to the membrane and it does not correlate with the qRT-PCR data ([Figure 4C](#fig4){ref-type="fig"}). The Western Blot should be either redone or left out.

4\) The main issues with this work relates to the discovery of an anti-silencing mechanism by SsrB induced DNA bending. The elegant experiments using AFM need to be supported with certain controls, primarily aimed at demonstrating specificity of binding of SsrB to the csgD regulatory region (and lack of binding to other H-NS silenced regions) in both AFM and electrophoretic mobility shift assays.

10.7554/eLife.10747.033

Author response

*\[...\] The title needs to be changed. The manuscript needs to be condensed. Some specific suggestions are provided in the detailed reviewer comments. There is thought that [Figure 1](#fig1){ref-type="fig"} is not relevant. Reviewer 2 has some specific concerns about [Figure 2](#fig2){ref-type="fig"}, [4](#fig4){ref-type="fig"} and [6](#fig6){ref-type="fig"} that require some attention and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} requires additional controls. There is some concern about whether the artificial invitro systems reflect the native situation. Some caution about interpretation is advised.*

The title has been changed and the manuscript has been condensed. [Figure 1](#fig1){ref-type="fig"} has been removed and we have supplied the additional controls as requested.

*Reviewer 3 would like to see additional biofilm data, \"It is therefore necessary to somehow quantify the entire population of Salmonellae in the tube and assess what fraction of it adheres. A true biofilm-defective mutant should show a shift from a fraction that adhere to the non-adhering planktonic population.\" Finally, Reviewer 3 points out that, \"The elegant experiments using AFM need to be supported with certain controls, primarily aimed at demonstrating specificity of binding of SsrB to the csgD regulatory region (and lack of binding to other H-NS silenced regions) in both AFM and electrophoretic mobility shift assays.*

These experiments are now provided.

Reviewer \#1:

*\[...\] There are several issues with the manuscript that the authors need to address. I present them here in the order in which they arise in the manuscript. 1) Title. \"To P or not to P\" conveys little information and might be appropriate for the Insight published along with the article. The rest of the title will make sense only to those working in the field. I would suggest something along the lines of \"An unphosphorylated two-component response regulator induces Salmonella Typhimurium biofilm genes by antisilencing a biofilm master-regulator gene.\"*

The title has been changed to: "The horizontally-acquired response regulator SsrB drives a *Salmonella* lifestyle switch by relieving silencing a biofilm master regulator".

*2) Key words. I think key words are meant to exclude words already appearing in a title.*

Redundant key words have been removed, although we left in two-component regulatory system.

*3) Abstract. Delete \"Remarkably.\" There is an overuse of emphasis words in general in the manuscript. I find this quite distracting. \"Highly upregulated\", unequivocally rule out, \"Sharp contrast\", etc. These all seem like overstatements to me.*

We have toned down the use of emphasis words.

*4) The Introduction is very long. It reads like the introduction to a thesis. I am not sure what might be condensed but it would be helpful to condense if possible.*

The Introduction has been condensed.

5\) Introduction, fourth paragraph. Delete \"Walthers and Kenny unpublished.\" It is not something the reader can refer to as are the publications referenced.

We have removed this reference.

*6) Last two paragraphs of the Introduction. As written it is confusing as to what the authors showed previously and what they are showing in this manuscript.*

This section has been reworded.

*7) Subsection "Unphosphorylated SsrB activates biofilm formation". I think the interpretations should be recast. First we learn that SsrA is not required for the biofilm phenotype. So it could be unphosphorylated B or B could be phosphorylated by an alternate donor. Then we learn that general donors like acetyl-P are not involved. So it could be unphosphorylated or there could be some sort of unknown cross talk with another sensor kinase. Finally we learn that Asp56, the residue phosphorylated by SsrA, can be mutated to an alanine and the protein still functions with respect to biofilm formation (but not SPI2 gene activation). This is good genetic evidence that the protein induces biofilm formation in an unphosphorylated form.*

We have presented these experiments with the same logic in the given order.

8\) Subsection "Unphosphorylated SsrB activates biofilm formation". This is an example of a sentence that needs rewriting. \"To confirm our hypothesis we examined...\". This is not the scientific method. Experiments are meant to be designed to disprove one's hypothesis. A simple wording change would provide a fix, for example: \"To test our hypothesis...\". This wording problem comes up in a few other places as well.

We have reworded these sentences.

*9) Subsection "Unphosphorylated SsrB activates biofilm formation". Change \"This is the first evidence\" to \"This provides evidence that\".*

This sentence has been changed.

*10) Subsection "SsrB and H-NS differentially regulate csgD expression", third paragraph. I am missing something here. I don\'t understand why the hypothesis explains why phosphorylation was not required.*

We rephrased this sentence to make it clear. Our earlier work with SsrB demonstrated that phosphorylation was required for in vitro transcription (Walthers et al., 2007; Walthers et al., 2011). This requirement is typical of response regulators that make direct contacts with RNAP (e.g. OmpR\~P interacts with a-CTD; Russo et al., 1993).

*11) Subsection "SsrB binds an H-NS stiffened nucleoprotein filament at csgD". The last sentences seem to describe a model based on the evidence presented rather than a proven mechanism and should be presented in this way. Particularly for the last sentence on RNAP I see no evidence in the manuscript.*

These sentences have been modified.

12\) Subsection "SsrB sits at a pivotal decision point that determines Salmonella lifestyles", first paragraph and elsewhere. \"It can de-repress HN-S at csgD\" seems like confusing jargon to me. Do the authors mean \"it can counter HN-S repression of csgD\" or \"counter HN-S silencing of"?

We changed the wording.

*13) Subsection "SsrB sits at a pivotal decision point that determines Salmonella lifestyles". Again I did not see any experiments about enabling access of RNAP. This seems logical but it should be presented as a model.*

We changed the wording here.

*14) The model is presented as a counterpoint to the idea that periplasmic histidines can play a role (\"we think this is unlikely\"). I got a little confused here about whether maybe both things could be true. Are they mutually exclusive?*

This paragraph has been reworded.

*15)"It is worth mentioning here that in our AFM images, it was apparent that H-NS was still bound to some regions of the csgD promoter when SsrB is condensing the DNA ([Figure 6A](#fig6){ref-type="fig"}(ii))". There is a mixture of tenses. I would change \"when SsrB is condensing\" to \"was condensing.\"*

Done.

*16) It seems like the whole first paragraph of the subsection "Structural homology does not indicate functional homology "could be deleted. I am not engaged by the fact that \"we were lulled into thinking that SsrB would behave like NarL.\" There are examples of transcriptional regulator families where some members require ligand binding to bind DNA and activate genes. They do this in the same way that NarL interacts with P to expose the DNA binding motif. Other members of the same family bind DNA and repress genes in the absence of ligand. The ligand blocks DNA binding.*

This paragraph has been modified.

*The last half of the last paragraph of the Discussion is maybe the fourth or fifth time the authors bring up the fact that their conclusion that HNS represses or silences csgD conflicts with the conclusion of Gerstal. Although this may be true, the way it is presented is not constructive. First, I believe this point should not be raised in the Results (as it is now). It is a point of discussion.*

We moved our description of this work to the Discussion.

*Second, I don\'t think, as it stands, it corrects the scientific record. If the authors want to discuss this they should make some attempt to resolve the conflict. Why do they think they arrived at a conclusion opposite that of Gerstel et al.? Are there strain differences? Did Gesrtel misinterpret or over-interpret a result? If the authors want to put any focus on the different conclusions then they should try to help us understand what might be a possibility. It is ok to say something about how at least with our strains and experimental protocols we find HNS silencing of csgD whereas Gerstel using a different whatever found HNS activation or whatever it is. It takes a level of brio to just claim ones results are more believable than others.*

We have softened this description and merely mention that our finding is different from theirs.

Reviewer \#2:

*In this manuscript the authors build on previous work demonstrating that the SsrAB regulators are important to Salmonella typhimurium biofilm formation. They determine that the SsrA histidine kinase is not required, but that the SsrB response regulator is required for biofilm formation as measured using methylene blue staining, Congo Red, and Calcofluor plates. They then analyzed the colonies formed in a microfluidic chamber in M9 medium in a flow cell and in cholesterol coated eppendorf tubes to further substantiate the biofilm phenotype The authors provide support for the lack of phosphorylation of SsrB being what is necessary for SPI2 regulation of curli genes responsible for biofilms by using SsrB phosphorylation deficient bacteria, with mutations in SsrA and the ability to produce acetyl phosphate. The requirement of SsrB to form biofilms was repressed by deletion of H-NS providing in vivo evidence that SsrB could act by competing or silencing H-NS based repression. The authors then provide evidence that SsrB/HNS bind to the csg promoter responsible for the synthesis of curli. The results add to our knowledge of Salmonellae gene regulation of biofilm formation, but do not really define where and how this may occur in vivo and/or what specific environmental conditions would lead to activation but not phosphorylation of SsrB.*

Our previous work showed that SsrA and SsrB are uncoupled; i.e., at neutral pH, the SsrA kinase is present at very low levels and it is induced in the acidic macrophage vacuole. SsrB levels are constant at pH 7 and pH 5.6 (Feng et al., 2004). We discovered this over ten years ago and always wondered why the regulator was present without its kinase. This work answers that question by assigning a role for unphosphorylated SsrB. We have tried to make this point more clear in the revised manuscript.

*Specific comments:*

*A great deal of data was not shown and this should be corrected prior to publication.*

We respectfully disagree with the reviewer on this point. We have only one example of "data not shown" in the manuscript and it is that the SEM images of D56A SsrB are similar to wt. This was after showing many images that indicate D56A is identical to wt in biofilm behavior. We can put this data in supplemental information if the reviewers wish.

*Throughout the manuscript the authors claim that they showed different results than that shown in Hamilton et al.*

We mention this once, because of the questions that previous work raised, e.g. SsrA was not required but SPI-2 genes were down-regulated. This didn't make sense, because SsrA/B up-regulates genes, this paradox led to the present investigation. We have re-worded our presentation of this work.

*However in this work the effect of an ssrA mutant on biofilm formation was complemented with a plasmid encoding both ssrA and ssrB. Therefore the results are likely a result of mutation of both genes or polarity.*

The previous study used a deletion of ssrA that was polar on the downsteam ssrB gene. This is now stated in the Discussion.

*Therefore the results are really similar and the authors have provided molecular detail as to the mechanism.*

*Since most of the paper is about mechanisms of transcription that lead to biofilm formation I am not sure what [Figure 1](#fig1){ref-type="fig"} adds to the manuscript.*

In response to Reviewer \#1, this figure has been removed.

*In [Figure 2D](#fig2){ref-type="fig"} the staining seems the same at 6 days. This is a surprising result, has the biofilm been formed that rapidly by another sensing mechanism?*

The staining is clearly not the same at 6 days in the *ssrB* null strain. We now show a different image that we hope makes this more obvious. It is clear that the wild type strain forms a network of typical mushroom-shaped macrocolonies by 6 d, by which time the *ssrB* strain has only managed to form lean aggregates.

*In [Figure 2F](#fig2){ref-type="fig"} why does the increase at later time points occur and why is it greater at 36 hours than at 47 and 69 hours? How many replicated experiments are represented by the figure and are the statistical analyses significant? This is not commented on in the figure legend.*

The *ssrB* strain is not completely defective in the formation of biofilms and similar to what we observe by confocal imaging of flow cell biofilms ([Figure 1D](#fig1){ref-type="fig"}), at about three days the amount of biofilms do increase marginally in the mutant. This is expected as apart from SsrB, a range of environmental conditions via other global regulators also regulates the expression of *csgD*. However, the *ssrB* mutant forms less biofilms than the wild type across all time points. The statistical details were missed before and have been included now.

*The phenotype of the SsrA mutant should be shown in [Figure 2B-D](#fig2){ref-type="fig"}.*

Since Reviewer \#3 requested that we reduce the biofilm results to a single figure (see point 1, below), we elected not to add more data as requested here (we have shown by all the other methods that the *ssrA* mutant is like the *wt*).

*The higher migrating signal in the western blot in [Figure 4D](#fig4){ref-type="fig"} is said to be non-specific in the figure legend. However, It is not present to a very great degree in the wild type and is greater in the SseA and D56A mutant and absent in ssrB mutants. What is this band and does it indicate another larger form of CsgD or has a different promoter been utilized when non-phosphorylated SsrB is present? This band should be isolated and protein sequenced to define its nature.*

We obtained a monoclonal antibody and now the western blot is completely clean and it is clear that csgD is absent in the ssrB null strain (new [Figure 3D](#fig3){ref-type="fig"}).

*What is the evidence that the binding angle observed in vitro with an artificial substrate by ATM reflects its ability to promote anti-silencing (subsection "Unphosphorylated SsrB binds to the csgD regulatory region", first paragraph)?*

In our in vitro experiments, we found that SsrB bends DNA, resulting in highly curved DNA conformations. This DNA binding property is distinct from H-NS, which forms rigid nucleoprotein filaments and thus straight DNA conformations. Bent DNA is therefore an energetically unfavorable substrate for H-NS binding, and a likely mechanism of SsrB-mediated anti-silencing of H-NS repressed genes. In a mixture of 600 nM H-NS and 600 nM SsrB ([Figure 6A](#fig6){ref-type="fig"}), we do not see evidence of sharply bent filaments. This is expected because H-NS dissociation is likely restricted to the filament ends. Such events occur due to the cooperative nature of H-NS binding that results in a chain of linked H-NS proteins. Hence, H-NS displacement by SsrB likely occurs progressively from the filament end. Indeed, we observed slow progressive H-NS filament dissociation in the presence of SsrB in single-molecule stretching experiments. We refer to Winardhi, Yan and Kenney (2015) for a more detailed discussion on H-NS anti-silencing by SsrB. Sentences to this effect have been added to the Discussion (subsection "The importance of anti-silencing in gene regulation", last paragraph).

*Again condensation on a silica binding substrate of a regulatory region on an increase of concentration of the protein that binds may or may not be biologically relevant in vivo (subsection "Unphosphorylated SsrB binds to the csgD regulatory region", last paragraph). The authors should reduce this speculation and consider performing the AFM in solution and under helium rather than nitrogen and see if similar results are obtained.*

We now include solution AFM, which shows the identical result as we presented previously (see [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

*The fact that HNS alters structure of DNA on a solid support does not reaffirm more than the biological data the mechanism by which HNS represses transcription, it just indicates under these conditions in binds to the DNA (subsection "SsrB binds an H-NS stiffened nucleoprotein filament at csgD", first paragraph*).

As noted above, we see the same results with solution AFM (see [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

*I think the data support a model in which SsrB alters the bending of DNA, though it seems this may not be a direct effect in vivo and the authors should soften the statement that they have identified the mechanism by which unphosphorylated SsrB regulates csgD.*

We have \>5 years' worth of collaborative research with the Yan lab on H-NS and other nucleoid associated proteins that indicate the mechanism of gene silencing is via a stiffened nucleoprotein filament and relief of silencing occurs by DNA bending proteins such as SsrB (Walthers et al., 2011; Lim et al., 2012; Liu et al., 2010, Lim et al., 2012(a) and 2012(b) (recently reviewed in Winardhi, Yan and Kenney (2015)). We now cite more of that work in the Discussion (subsection "The importance of anti-silencing in gene regulation").

*I am not sure the authors are correct in their ideas about SsrB function controlling extracellular lifestyle of Salmonellae since there are many growth conditions in which ssrAB are not expressed and the bacteria can form biofilms. Hence this may be most important for the expression of a biofilm under certain conditions of SPI2 expression but not SsrA activation as a kinase. This may actually occur inside host cells and recent evidence of cellulose expression in host cells and past work showing curli biosynthesis genes can be regulated by RpoS may suggest that they are expressed inside of host cells and hence the authors results may be most relevant to how curli may be expressed inside of host cells rather than SsrAB being another host switch more like PhoPQ.*

I am not sure what the reviewer is getting at here. Our previous work (Feng et al. 2004) and our current laboratory has examined SsrB and found it to be constitutive under all the conditions we tested (most recently using super-resolution imaging). So, we disagree with the reviewer on this point. We also do not know of any examples of SPI-2 expression without SsrA activation, since every SPI-2 gene that we have tested required SsrB\~P for in vitro transcription (Walthers et al., 2007; Walthers et al., 2011).

*The title contains this "to P or not to P", which I found confusing and relatively unscientific since it does not represent PO4. This should probably be changed prior to publication.*

Done.

*In [Figure 6---figure supplement 2](#fig6s1){ref-type="fig"}, why is so little shifting seen with SsrB in the absence of HNS? Is the affinity very low? Additional controls should include SsrB without the anti-ssrB antibody that causes the super shift. Is no binding seen without HNS? If the AFM is significant, binding should be seen without HNS present.*

We now include additional controls in the revised EMSA (see [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"} and [Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}). In the AFM, SsrB binding and bending occurs at 120 nM, which is pretty high affinity for an unphosphorylated protein (e.g. OmpR binds to ompF and ompC with a Kd of 150 nM (Head et al., 1998). We also included a DNA binding mutant K179A (Carroll et al., 2009) and it clearly does not bind, so we demonstrate specificity as well. We also show that the EMSA complex formed by SsrB on *csgD~122~* can be dissociated by the addition of excess unlabeled *csgD~122~* fragment.

*The data would be strengthened by footprinting and defining the specific promotor sequences bound by SsrB and H-NS prior to publication.*

We now include the SsrB binding region based on the AFM (755 bp fragment) and the EMSA (122 fragment) taking into consideration the H-NS binding region (Gerstel et al., 2003), and all of our previous mapping and identifying of SsrB binding sites ([Figure 6---figure supplement 4](#fig6s4){ref-type="fig"}) (Walthers et al., 2007; Walthers et al., 2011).

Reviewer \#3:

*The authors present a series of experiments demonstrating a novel role for a two component regulatory system, implicated in the virulence and persistence of Salmonella enteritica. The main novel aspects of the findings described in the manuscript are: 1. Demonstration that the SsrB response regulator is a molecular switch, reciprocally controlling two sets of traits associated with virulence (the expression of a type III secretion system) and biofilm formation; (2) Defining an active function for an un-phosphorylated response regulator; (3) Elucidation of a novel regulatory mechanism for a response regulator activity (anti-silencing) by DNA bending and (4) evolutionary implications for acquisition of a regulatory system by horizontal gene transfer, controlling the expression of core, chromosomal genes. Overall, this paper contains substantial amount of new results (in quality and in quantity) and represents information with broad interest to those readers who are interested in new molecular mechanisms of gene regulation, strategies of pathogenic organism capable of causing acute and chronic infections and their evolution. This is important work, established a new paradigm for two-component signaling. The only concern is with a few technical points related to certain experiments and a need for a few additional controls.*

We are thrilled to read that the reviewer understands the importance of our findings.

Reviewer \#3 (Minor comments):

There are a few minor issue that the authors should address, mainly to make the manuscript more readable and highlighting its strongest points. 1) There is excessive amount of data on attempts to demonstrate that the absence of SsrB has an effect on biofilm formation. That could be simply reduced to a single figure comparing ssrB deletion with point mutants in SsrA and SsrB.

2\) The major biofilm assay used in this work is based on adherence of bacteria to the sides of polystyrene tubes. This method actually measures only adhesion of the bacteria to their biofilm phenotype. A simple growth defect of the ssrB mutant would be also reflected as a decrease in adherence and erroneously concluded as a defect in biofilm formation. It is therefore necessary to somehow quantify the entire population of Salmonellae in the tube and assess what fraction of it adheres. A true biofilm-defective mutants should show a shift from a fraction that adhere to the non-adhering planktonic population.

Firstly, we present growth curves that indicate there is no growth defect (presented in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Secondly, we assessed the adhering vs. non-adhering cells in each population (Mackenzie et al., 2015) ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} and [3](#fig1s3){ref-type="fig"}) and found that the adherent fraction was lower in the *ssrB* strain compared to the wild type, *ssrA* and D56A strains but, there were greater number of cells in the non-adherent sub-population for the *ssrB* mutant.

*3) [Figure 4D](#fig4){ref-type="fig"} is rather un-convincing; the lane containing the D56A mutant indicates some problems with transfer of CsgD from gels to the membrane and it does not correlate with the qRT-PCR data ([Figure 4C](#fig4){ref-type="fig"}). The Western Blot should be either redone or left out.*

As mentioned above, we re-did the western blot with a monoclonal antibody and we now present it ([Figure 3D](#fig3){ref-type="fig"}).

*4) The main issues with this work relates to the discovery of an anti-silencing mechanism by SsrB induced DNA bending. The elegant experiments using AFM need to be supported with certain controls, primarily aimed at demonstrating specificity of binding of SsrB to the csgD regulatory region (and lack of binding to other H-NS silenced regions) in both AFM and electrophoretic mobility shift assays.*

As mentioned above in response to Reviewer \#2, these controls are now included for both AFM and EMSA. The K179A mutant clearly does not bind to DNA, demonstrating specificity ([Figure 5E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}).
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